Law Offices of Howard G. Smith Announces Investigation of CR Intrinsic Investors, LLC

... disclosing disappointing clinical trial results for the drug bapineuzumab (AAB-001) ("bapi"). Bapi was an Alzheimer's disease treatment that was being jointly developed by Wyeth and Elan Corporation, plc. On June 17, 2008 Wyeth released top-line ...

http://technews.tmcnet.com/news/2013/04/15/7063854.htm